Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

AstraZeneca is an innovation-driven biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines that make a meaningful difference in healthcare. AstraZeneca discovers new medicines that are designed to improve the health and quality of life of patients around the world - medicines that are innovative, effective, and which offer added benefits such as reduced side effects or better ways of taking the treatment. AstraZeneca focuses on getting the best from every medicine they make by exploring all the ways it can be used or improved. AstraZeneca was established on April 6, 1999, in Cambridgeshire, United Kingdom.

BC Cancer Agency provides healthcare services. The firm serves for hereditary cancer, indigenous cancer care, interpreters, and psychiatry. Its services include assessment and follow-up library, nutrition services, pain and symptom management, patient and family counselling, PET functional imaging, primary care, screening programs, and speech-language pathology. The company was founded on November 5, 1938 and is headquartered in Vancouver, Canada.

Perceptronix Medical, Inc. provides cytology laboratory and cancer diagnostics services. It provides partnership opportunities for the distribution and test sales of quantitative cytology imaging machine including ClearCyte. The firm also provides software and staining kit Clear2C. Its products are used in hospitals, universities and commercial laboratories. The company was founded in 1999 and is headquartered in Vancouver, Canada.

Creative Antibiotics AB engages in the manufacture of pharmaceuticals products. The company was founded in 2000 and is headquartered in Umeå, Sweden.

Verisante Technology, Inc. a medical device company, which is engaged in development, regulatory, production and commercialization of skin cancer detection systems. Its products include verisante aura and verisante core. The verisante aura is a multimodality imaging and spectroscopy system designed to aid in the early detection of skin cancer. The verisante core is designed to aid in the early detection of other cancers, which includes lung, colon and cervical. verisante technology was founded by Thomas A. Braun on March 7, 2006 and is headquartered in Vancouver, Canada.

AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis.

Zeneca is a British multinational pharmaceutical company focused on therapeutic oncology and cardiovascular products. Zeneca was established in June 1993 through a demerger of the pharmaceuticals and agrochemicals businesses of Imperial Chemical Industries. In 1999 Zeneca and Astra AB, a Sweden-based pharmaceutical company, merged to form AstraZeneca plc.

Lena Biosciences is a biotechnology company offering advanced, organ-on-a-chip and 3D cell culture products for precision therapies, biomedical research and drug testing. Its new PerfusionPal product is a high-throughput organ-on-a-chip insert system that yields up to 5 times greater drug metabolism. It fits into existing workflows and enables customers to emulate multiple organs, deliver and test drugs in a standard format for ADME Tox screening, cancer research, and precision therapies. Owing to concentrated secretome and metabolome, PerfusionPal is ideally suited for testing slow-to-metabolize drugs and biologics (monoclonal antibodies and antibody-drug conjugates).

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Shenzhen Huajing Baofeng Electronics Co., Ltd., established on 2003-01-27, Business scope includes general business items:Electronic products and components,Instrumentation,Electromechanical equipment and accessories,Chemical Products(non-flammable,Explosive,Highly toxic and other dangerous goods)purchase and sale(Does not contain franchise,Exclusive control,Monopoly);Import and export,Technology Import and Export(law,Except for items prohibited by administrative regulations;law,Projects restricted by administrative regulations must be licensed before they can be operated);Operating e-commerce,Information Consulting(No restricted items).Lighting Sales;Electronic Components Retail;Wholesale of electronic components;IC sales.,The licensing program is:sensor,Production of electronic modules;transformer,Rectifier and inductor manufacturing;Manufacturing of lighting fixtures;Manufacturing of electronic components;integrated circuit manufacturing;Integrated circuit chip and product manufacturing.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Zhengzhou Hengzhijie Electronic Technology Co., Ltd., established on 2011-04-29, Business scope includes electronic product technology development(Non-development);computer software development;computer graphic design(Except for special regulations of the state);design,make,Agency to release domestic advertising business;Wholesale and retail:electronic product,communication equipment,Computer hardware and software.(above range,National law,Except for projects that require examination and approval as required by administrative regulations and rules)

Central Institute for Experimental Animals (CIEA) (実験動物中央研究所) is a research center for experimental animals in Japan. It was founded by Tatsuji Nomura in 1952 with the mission of improving the level of biomedical research.

Syngenta AG is a global company that produces agrochemicals and seeds and is based in Basel, Switzerland. As a biotechnology company, it conducts genomic research. It was formed in 2000 by the merger of Novartis Agribusiness and Zeneca Agrochemicals. As of 2014 Syngenta is the world’s largest crop chemical producer As of 2009 it ranked third in seeds and biotechnology sales. Sales in 2015 were approximately US$13.4 billion, over half of which were in emerging markets. It is owned by ChemChina, a Chinese state-owned enterprise.

Engages in noninvasive testing of bone integrity